Key result
PUFA analogues with glycine head groups selectively activated Kv7.1/KCNE1 channels and suppressed early afterdepolarizations in simulated cardiomyocytes.
Why the study?
Mutations in voltage-gated ion channels cause Long QT Syndrome (LQTS), and polyunsaturated fatty acids have emerged as potential therapeutics because they modulate these channels.
Do different PUFA analogues selectively modulate cardiac voltage-gated ion channels to shorten action potential duration in preclinical models of Long QT Syndrome?
Do different PUFA analogues selectively modulate cardiac voltage-gated ion channels to shorten action potential duration in preclinical models of Long QT Syndrome?
Answers are grounded in this paper and cite their sources.
PUFA analogues demonstrate unique, head-group-dependent selectivity for specific cardiac ion channels, providing a mechanistic foundation to tailor PUFA-based therapeutics for specific Long QT Syndrome subtypes.
The cardiac ventricular action potential depends on several voltage-gated ion channels, including Na v , Ca v , and K v channels. Mutations in these channels can cause Long QT Syndrome (LQTS) which increases the risk for ventricular fibrillation and sudden cardiac death. Polyunsaturated fatty acids (PUFAs) have emerged as potential therapeutics for LQTS because they are modulators of voltage-gated ion channels. Here we demonstrate that PUFA analogues vary in their selectivity for human voltage-gated ion channels involved in the ventricular action potential. The effects of specific PUFA analogues range from selective for a specific ion channel to broadly modulating all three cardiac ion channels (N aV , C aL , and I Ks ). In addition, PUFA analogues do not modulate these channels through a shared mechanism. Our data suggest that different PUFA analogues could be tailored towards specific forms of LQTS, which are caused by mutations in distinct cardiac ion channels, and thus restore a normal ventricular action potential.
No takes yet. Share an insight, caveat, or question.
Bohannon et al. (2019) studied Long QT Syndrome (preclinical models). Polyunsaturated fatty acid (PUFA) analogues vs. Baseline/control conditions was evaluated on Shift in voltage-dependence of activation/inactivation and maximal conductance. PUFA analogues with glycine head groups selectively activated Kv7.1/KCNE1 channels and suppressed early afterdepolarizations in simulated cardiomyocytes.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: